PET, SPECT Infusion Enhancements Streamline Infusion Scheduling
|
By MedImaging International staff writers Posted on 29 May 2012 |
|
Platforms have been developed for the controlled administration of molecular agents for single photon emission tomography (SPECT) as well as information technology (IT) enhancements to streamline positron emission tomography (PET) infusion scheduling.
Bayer Healthcare--Radiology & Interventional (Tarrytown, NY, USA) will present new device technologies at the annual meeting of the Society of Nuclear Medicine (SNM) in Miami (FL, USA), June 9-13, 2012. The new technology includes enhancements to the Intego PET infusion system, as well as developing platforms for controlled administration of molecular agents for SPECT and small animal imaging procedures.
In PET, the Medrad Intego system is a worldwide market leader and the only US Food and Drug Administration (FDA)-cleared system for administration of 18F-fluorodeoxyglucose (FDG) and 18F-sodium fluoride (NaF). Bayer has continued to advance and evolve the Intego platform since its launch in 2008, including adding software features, expanding compatibility and indications, and considerably reducing the size of the device. At SNM, Bayer plans to demonstrate Certegra informatics systems for Intego, including wireless integration to hospital information systems/radiology information systems/picture archiving and communication systems (HIS/RIS/PACS), which simplify downloading the PET modality worklist as an infusion schedule and sending infusion results to PACS. This new capability will replace several manual processes, which subsequently will streamline workflow and improve efficiency for PET imaging clinics.
Doug Descalzi, Bayer senior director of molecular devices, said, “Automated, controlled injection of molecular agents not only has safety and workflow benefits for staff, it can lead to improvements in patient care and help clinicians
Moreover, the company will present developing technologies for controlled administration of low energy radiopharmaceuticals and for small animal molecular imaging in a scientific exhibition.
The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer, AG (Leverkusen, Germany, is one of the world’s leading companies in the healthcare and medical products industry. The company combines the global activities of the animal health, consumer care, medical care, and pharmaceuticals divisions.
Related Links:
Bayer Healthcare
Bayer Healthcare--Radiology & Interventional (Tarrytown, NY, USA) will present new device technologies at the annual meeting of the Society of Nuclear Medicine (SNM) in Miami (FL, USA), June 9-13, 2012. The new technology includes enhancements to the Intego PET infusion system, as well as developing platforms for controlled administration of molecular agents for SPECT and small animal imaging procedures.
In PET, the Medrad Intego system is a worldwide market leader and the only US Food and Drug Administration (FDA)-cleared system for administration of 18F-fluorodeoxyglucose (FDG) and 18F-sodium fluoride (NaF). Bayer has continued to advance and evolve the Intego platform since its launch in 2008, including adding software features, expanding compatibility and indications, and considerably reducing the size of the device. At SNM, Bayer plans to demonstrate Certegra informatics systems for Intego, including wireless integration to hospital information systems/radiology information systems/picture archiving and communication systems (HIS/RIS/PACS), which simplify downloading the PET modality worklist as an infusion schedule and sending infusion results to PACS. This new capability will replace several manual processes, which subsequently will streamline workflow and improve efficiency for PET imaging clinics.
Doug Descalzi, Bayer senior director of molecular devices, said, “Automated, controlled injection of molecular agents not only has safety and workflow benefits for staff, it can lead to improvements in patient care and help clinicians
Moreover, the company will present developing technologies for controlled administration of low energy radiopharmaceuticals and for small animal molecular imaging in a scientific exhibition.
The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer, AG (Leverkusen, Germany, is one of the world’s leading companies in the healthcare and medical products industry. The company combines the global activities of the animal health, consumer care, medical care, and pharmaceuticals divisions.
Related Links:
Bayer Healthcare
X-Ray Illuminator
X-Ray Viewbox Illuminators
Silver Member
X-Ray QA Meter
T3 AD Pro
New
Ultrasound Needle Guide
Ultra-Pro 3
Portable X-ray Unit
AJEX140H
Latest Nuclear Medicine News
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
- New Immuno-PET Imaging Technique Identifies Glioblastoma Patients Who Would Benefit from Immunotherapy
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read more
MRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg "Image: The AI-powered lung ultrasound tool outperformed human experts by 9% in diagnosing TB (Photo courtesy of Adobe Stock)")
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
General/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more